Literature DB >> 12628463

Rat arteries contain multiple nicotinic acetylcholine receptor alpha-subunits.

Dörthe Brüggmann1, Katrin S Lips, Uwe Pfeil, Rainer V Haberberger, Wolfgang Kummer.   

Abstract

We investigated the occurrence and distribution of the ligand-binding alpha-subunits of nicotinic acetylcholine receptors in the rat arterial system in situ by means of RT-PCR and immunohistochemistry. Except the alpha9-subunit, all other mammalian non-muscular alpha-subunits were expressed in the arterial wall--either in endothelial or in smooth muscle cells--suggesting it as a direct target of nicotine and endogenous acetylcholine. The distribution pattern of alpha-subunits found in smooth muscle cells varied considerably among the individual elastic, muscular and intraparenchymal arteries investigated, suggesting that non-neuronal cholinergic signalling via nicotinic receptors in the vascular wall includes components that are highly specific for individual arteries. Copyright 2003 Elsevier Science Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12628463     DOI: 10.1016/s0024-3205(03)00067-5

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  10 in total

Review 1.  α-Conotoxins active at α3-containing nicotinic acetylcholine receptors and their molecular determinants for selective inhibition.

Authors:  Hartmut Cuny; Rilei Yu; Han-Shen Tae; Shiva N Kompella; David J Adams
Journal:  Br J Pharmacol       Date:  2017-06-11       Impact factor: 8.739

2.  Systemic peptide mediated delivery of an siRNA targeting α-syn in the CNS ameliorates the neurodegenerative process in a transgenic model of Lewy body disease.

Authors:  Brian Spencer; Ivy Trinh; Edward Rockenstein; Michael Mante; Jazmin Florio; Anthony Adame; Omar M A El-Agnaf; Changyoun Kim; Eliezer Masliah; Robert A Rissman
Journal:  Neurobiol Dis       Date:  2019-03-05       Impact factor: 5.996

3.  Targeted delivery of proteins into the central nervous system mediated by rabies virus glycoprotein-derived peptide.

Authors:  Ailing Fu; Yilin Wang; Liping Zhan; Rumei Zhou
Journal:  Pharm Res       Date:  2012-01-10       Impact factor: 4.200

Review 4.  Acetylcholine beyond neurons: the non-neuronal cholinergic system in humans.

Authors:  I Wessler; C J Kirkpatrick
Journal:  Br J Pharmacol       Date:  2008-05-26       Impact factor: 8.739

Review 5.  Alpha9 nicotinic acetylcholine receptors and the treatment of pain.

Authors:  J Michael McIntosh; Nathan Absalom; Mary Chebib; Ana Belén Elgoyhen; Michelle Vincler
Journal:  Biochem Pharmacol       Date:  2009-05-27       Impact factor: 5.858

6.  Nicotinic acetylcholine receptor mediates nicotine-induced actin cytoskeletal remodeling and extracellular matrix degradation by vascular smooth muscle cells.

Authors:  Zhizhan Gu; Vera Fonseca; Chi-Ming Hai
Journal:  Vascul Pharmacol       Date:  2012-08-23       Impact factor: 5.773

Review 7.  Nicotine and vascular dysfunction.

Authors:  Anna K Whitehead; Abigail P Erwin; Xinping Yue
Journal:  Acta Physiol (Oxf)       Date:  2021-02-24       Impact factor: 6.311

Review 8.  Electronic Cigarette Use and the Risk of Cardiovascular Diseases.

Authors:  Jorge Espinoza-Derout; Xuesi M Shao; Candice J Lao; Kamrul M Hasan; Juan Carlos Rivera; Maria C Jordan; Valentina Echeverria; Kenneth P Roos; Amiya P Sinha-Hikim; Theodore C Friedman
Journal:  Front Cardiovasc Med       Date:  2022-04-07

9.  Progressive brain changes in patients with chronic fatigue syndrome: A longitudinal MRI study.

Authors:  Zack Y Shan; Richard Kwiatek; Richard Burnet; Peter Del Fante; Donald R Staines; Sonya M Marshall-Gradisnik; Leighton R Barnden
Journal:  J Magn Reson Imaging       Date:  2016-04-28       Impact factor: 4.813

Review 10.  Nicotine in Senescence and Atherosclerosis.

Authors:  Ann Marie Centner; Pradeep G Bhide; Gloria Salazar
Journal:  Cells       Date:  2020-04-22       Impact factor: 6.600

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.